The global  Active Pharmaceutical Ingredient (API) market, valued at USD 239.45 billion in 2023, is projected to grow significantly, reaching USD 371.06 billion by 2032. This growth is anticipated at a compound annual growth rate (CAGR) of 5.37% from 2024 to 2032. The market expansion is fuelled by rising demand for generic drugs, increased healthcare needs, and innovations in drug...